# BridgeBio Pharma, Inc.: Form 8-K, filed Nov 19, 2019

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 8-K
- Filed: 2019-11-19
- Accepted by EDGAR: Nov 19, 2019, 16:30 ET
- Period: 2019-11-13
- Accession: 0001193125-19-295582
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000119312519295582/d24594d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000119312519295582/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000119312519295582/d24594d8k.htm

Filed Nov 19, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-295582. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
